Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged ProstateCompared to Leading Surgical Treatments
November 14, 2023
WAYNE, Pa., November 14, 2023 -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announced today that a new...
Read MoreTeleflex Completes Acquisition of Palette Life Sciences
October 10, 2023
WAYNE, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced...
Read MoreNew Survey Highlights the Quality of Life Impact of an Enlarged Prostate
September 12, 2023
Men With Bothersome Urinary Symptoms Find Travel Less Enjoyable Due to Frequent Bathroom Needs
Read MoreTeleflex to Acquire Palette Life Sciences
July 26, 2023
Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolio
Read MoreNew Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
May 3, 2023
Research Presented at the American Urological Association Annual Meeting Confirms Five-Year Durability of UroLift® System and Highlights Low Rates of...
Read MoreUroLift® System Research Data from EAU Highlight Durability and Superior Patient Experience, Along with Benefits of Earlier Treatment for BPH
March 13, 2023
Presentations at the 38th Annual European Association of Urology Congress Reinforce Low Surgical Retreatment of the UroLift® System
Read MoreTeleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
February 6, 2023
The campaign drives education about the importance of regular health screenings and treatment options for benign prostatic hyperplasia (BPH), a...
Read MoreTeleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System
December 15, 2022
WAYNE, Pa., December 15, 2022 -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that 400,000...
Read MorePublished Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
October 25, 2022
Men with obstructive median lobes treated with the UroLift® System experience symptom improvement sooner and are satisfied more quickly compared to...
Read MoreTeleflex Announces Collaboration with FundamentalVR, to Improve Training Through Virtual Reality Simulation
August 25, 2022
FundamentalVR Offers Teleflex a Scalable Training Platform to Accelerate the Effective Use of the UroLift® 2 System for Treatment of Enlarged Prostate
Read More
